HOLLY MARK SPENCER
OKLAHOMA CITY, OK
Browse related groups: OK Amgen Inc. All categories
This page merges CMS profile IDs: 11283221, 11310087 (associated profiles published by CMS for the same provider; see the provenance section below).
General Payments — all program years on this page
$5,899.52
- Category: General Payments
- Program years: PY2021–2024
- Record count: 252
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $817.40 across 42 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $801.79 | 41 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15.61 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $113.67 | 5 |
| Novo Nordisk AS | $102.43 | 5 |
| Bayer HealthCare Pharmaceuticals Inc. | $83.81 | 5 |
| Acerta Pharma LLC | $78.35 | 5 |
| Janssen Pharmaceuticals, Inc | $66.48 | 3 |
| Alnylam Pharmaceuticals Inc. | $48.56 | 2 |
| PFIZER INC. | $41.48 | 2 |
| Esperion Therapeutics, Inc. | $33.76 | 2 |
| Azurity Pharmaceuticals, Inc. | $31.83 | 2 |
| Abbott Laboratories | $29.69 | 1 |
| Medtronic, Inc. | $28.35 | 1 |
| Merck Sharp & Dohme Corporation | $22.27 | 1 |
| ATRICURE, INC. | $20.77 | 1 |
| SCPHARMACEUTICALS INC. | $18.45 | 1 |
| IMPULSE DYNAMICS (USA) INC. | $18.12 | 1 |
| CHIESI USA, INC. | $16.45 | 1 |
| Lilly USA, LLC | $16.34 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.91 | 1 |
| Medicure Pharma Inc. | $15.61 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.07 | 1 |
By program year
Records — PY2024 (42)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
- Merged CMS profile IDs: 11283221, 11310087
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.